Previous ArticlesNext Articles
WANG Bao-lei,WANG Jia,GUO Chun-yan
Online:
2017-10-26Published:
2017-12-01Contact:
郭春燕,E-mail:18931316689@163.comAbout author:
王保磊,E-mail:358512557@qq.comCLC Number:
WANG Bao-lei,WANG Jia,GUO Chun-yan.Study on Antithrombotic Mechanism Based on Platelet Pathway[J]. Acta Neuropharmacologica,DOI: 10.3969/j.issn.2095-1396.2017.05.006.
[1]贾俊.红花注射抗血栓药效物质基础初步研究[D].太原:山西大学, 2010.
[2]Martine Gilard, Paul Barragan, Arif A L Noryani.6- versus 24-month dual antiplatelet therapy after implantation of drug-eluting stents in patients nonresistant to aspirin: the randomized, multicenter ITALIC trial[J].J Am coll cardiol, 2015, 65(8):777-786.
[3]周铭.血小板聚集功能的检测——光谱学及软X线成像研究[D].合肥:安徽医科大学, 2016.
[4]王晓锋,陈乃宏,王文.抗血小板聚集药物的机制研究进展[J].中国康复理论与实践, 2010, 16(10): 954-957.
[5]Shaturny? V I, Shakhidzhanov SS, Sveshnikova AN, Panteleev MA.Activators, receptors and signal transduction pathways of blood platelets[J]. Biomed Khim. 2014, 60(2):182-200
[6]Liu Yang-yang, Hu Meng-jiao. Luo Dong-jiao,et al.Class III PI3K Positively Regulates Platelet Activation and Thrombosis via PI(3)P-Directed Function of NADPH Oxidase[J]. Arterioscler Thromb Vasc Biol, 2018, 38(3): e26-e27.
[7]Zoubir Djerada, Catherine Feliu, Vincent Richard.Current knowledge on the role of P2Y receptors in cardioprotection against ischemia-reperfusion[J]. Pharmacol Res, 2017, 118: 5-18.
[8]陆四,孟照辉.血小板膜蛋白受体信号转导通路的研究进展[J].医学综述, 2014, 20(21): 3851-3854.
[9] Atkinson L, Yusuf1 M.Z, Aburima A,et al.Reversal of stress fibre formation by Nitric Oxide mediated RhoA inhibition leads to reduction in the height of preformed thrombi[J]. Sci Rep, 2018, 8(1):3032
[10] Yusuf M Z, Raslan Z, Atkinson L,et al.Prostacyclin reverses platelet stress fibre formation causing platelet aggregate instability[J]. Scientific, 2017, 7(1): 5582
[11]Wu Chin-chung, Teng Che-ming.Comparison of the effects of PAR1 antagonists, PAR4 antagonists, and their combinations on thrombin-induced human platelet activation[J]. Eur J Pharmacol, 2006, 546(1-3): 142-47.
[12]余果宇,张勇,江萍.蛋白酶激活受体[J].生命的化学, 2011, 31(03): 425-428.
[13] Beatrice Hechler, Christian Gachet.P2 receptors and platelet function[J]. Purinergic Signal, 2011, 7(3): 293-303
[14]Pia R M Siljander, Imke C A Munnix, Peter A Smethurst,et al.Platelet receptor interplay regulates collagen-induced thrombus formation in flowing human blood[J]. Blood, 2004, 103(4): 1333-1341.
[15]Jane F Arthur, Elizabeth Gardiner, Maria Matzaris,et al.Glycoprotein VI is associated with GPIb-IX-V on the membrane of resting and activated platelets[J]. Thromb Haemost, 2005, 93(4): 716-23.
[16]李雪晴,耿婷.血小板活化因子(PAF)受体拮抗剂的研究进展[J].中国中药杂志, 2018, 24(04): 1392-1403
[17] Federico Iovino, Matthijs C Brouwer, Diederik van de Beek,et al.Signalling or binding: the role of the platelet-activating factor receptor in invasive pneumococcal disease[J]. Cell Microbiol, 2013, 15(6): 870-881
[18] Omair Yousuf, Deepak L Bhatt.The evolution of antiplatelet therapy in cardiovascular disease[J]. Nat Rev Cardiol, 2011, 8(10): 547-59.
[19]Gu X, Fu X, Wang Y,et al. Comparison of ticagrelor and high-dose clopidogrel on the platelet functions in patients with inadequate response to clopidogrel [J]. Am J Cardiovasc Dis, 2017, 7(1):1-8
[20]董慧宇,陈献华. P2Y12受体拮抗剂类抗血小板药物的研究新进展[J].中国新药杂志,2017, 26(12):1406-1411
[21] Beatrice Hechler, Christelle Nonne, Eun Joo Roh,et al.MRS2500 [2-iodo-N6-methyl-(N)-methanocarba-2'-deoxyadenosine-3',5'-bisphosphate], a potent, selective, and stable antagonist of the platelet P2Y1 receptor with strong antithrombotic activity in mice[J]. J Pharmacol Exp Ther, 2006, 316(2): 556-63.
[22] Maree A O, Cox D, Fitzgerald D J.Drug insight: aspirin resistance-fact or fashion? [J]. Nat Clin Pract Cardiovasc Med, 2007, 4(3): E1
[23] Xu Li-na, Yu Wen-gui, Tian Jin-ying,et al.Effectof sodium ferulate on arachidonic acid metabolism[J]. Acta Pharm Sin, 1990, 25(6) : 412-416.
[24] Jantan I, Raweh S M, Sirat H M,et al.Inhibitory effect of compounds from Zingiberaceae species on human platelet aggregation[J].Phytomedicine, 2008, 15(4): 306-309
[25] Marilena Crescente, Gisela Jessen, Stefania Momi,et al.Interactions of gallic acid, resveratrol, quercetin and aspirin at the platelet cycloox-ygenase-1 level. Functional and modelling studies[J]. Thromb Haemost, 2009, 102(2): 336-346.
[26]张林山. PAR-1受体拮抗剂E5555类似物的研究[D].青岛:青岛科技大学,2012.
[27] Shinya Goto, Testu Yamaguchi, Yasuo Ikeda,et al.Safety and exploratory efficacy of the novel thrombin receptor(PAR-1) antagonist SCH530348 for non-ST-segment elevation acute coronary syndrome[J]. J Atheroscler. Thromb, 2010, 17 (2): 156-164.
[28] Jennifer Vergara-Jimenez, Pierluigi Tricoci.Safety and efficacy of abciximab as an adjunct to percutaneous coronary intervention[J]. Vasc Health Risk Manag, 2010, 6: 39-45.
[29]陈俞宏,李孝成.低分子肝素结合替罗非班治疗老年急性下肢深静脉血栓对PAC-1、P选择素的影响[J].中国现代医学杂志, 2018, 28(03): 64-68
[30]高稳,李健.ERK5对体外血小板活化及在体血栓的影响[J].中国病理生理杂志, 2017, 33(11): 1958-1963
[31]Li Wei, Yue Hong.Thymidine phosphorylase: A potential new target for treating cardiovascular disease[J]. Science Direc, 2018, 28(3): 157-171
[32]Diana A Gorog, Zahi A Fayad, Valentin Fuster.Arterial thrombus stability: does it matter and can we detect it? [J]. J Am Coll Cardiol, 2017, 70(16): 2036–2047.
|
[1] | LIU Hui-juan,BAI ming,MIAO Ming-san.Application and Analysis of Chinese Patent Medicine Containing Gastrodia elata Blume[J]. Acta Neuropharmacologica, 2019, 9(6): 26-30. |
[2] | LIANG Yu-fei,ZHANG Xin-xin,ZHAO Li-yan,et al.Discussed the Application of Curcumin Combined with Piperine Based on the Metabolic Characteristics of Curcumin[J]. Acta Neuropharmacologica, 2019, 9(6): 47-57. |
[3] | SONG Yi-lei,HOU Xue-qin,HAO Ji-fu.Advances in Research on Modern Pharmacological Effects and Clinical Application of Cnidium[J]. Acta Neuropharmacologica, 2019, 9(6): 58-63. |
[4] | ZHAO Peng-hui,PANG Ce,ZHEN Pan.A New Idea to Treat Glioma with Mulberin[J]. Acta Neuropharmacologica, 2019, 9(5): 44-49. |
[5] | YANG-Lin,AI-Jing.Research Progress of Brain-Derived Estrogen in Alzheimer’s Disease[J]. Acta Neuropharmacologica, 2019, 9(5): 50-64. |
[6] | MIAO Ming-san,PENG Meng-fan,FANG Xiao-yan,JIA Jiao-jiao,BAI Ming.Effects of Sargentodoxacuneata Total Phenolic Acids on Oxidative Stress Level and Energy Metabolism of Brain Tissues in Rats with Cerebral Ischemia Reperfusion Injury[J]. Acta Neuropharmacologica, 2019, 9(1): 1-5. |
[7] | DI Tong,ZHAO Zhi-jie,BAO Jin-feng.Preliminary Study on the Effect of Folic Acid on Anxiety-Like Behavior in Adult Mice Induced by Maternal Separation[J]. Acta Neuropharmacologica, 2019, 9(1): 6-12. |
[8] | WU Xian,HONG Hao.Bile Acids and Their Receptors are Associated with Central Nervous System Diseases[J]. Acta Neuropharmacologica, 2019, 9(1): 23-30. |
[9] | WEI Zhen-zhen,FANG Xiao-yan,BAI Ming,MIAO Ming-san.Research Progress in Treatment of Cerebral Ischemia Injury Based on Astrocytes[J]. Acta Neuropharmacologica, 2019, 9(1): 36-43. |
[10] | ZHANG Dan-shen,SU Xiao-mei.Role of N-Methyl-D-Aspartate Receptor in Memory Network[J]. Acta Neuropharmacologica, 2019, 9(1): 44-62. |
[11] | ZHANG Shuai,AI Jing.Glutamate Dysfunction and Alzheimer’s Disease[J]. Acta Neuropharmacologica, 2018, 8(6): 9-20. |
[12] | ZHANG Hai-wei1, ZHANG Dan-shen2, SU Xiao-mei2, ZHAO Kai-yan2, WU Chun-yang1, ZHANG Li1.Study on the Establishment of an in vitro Blood-Cerebrospinal Fluid Barrier Model[J]. Acta Neuropharmacologica, 2018, 8(3): 1-8. |
[13] | XING Yuan,ZHANG Nan,ZHANG Wei,REN Lei-ming.Neurotoxicity and Prevention of Local Anesthetics in Central Nervous System[J]. Acta Neuropharmacologica, 2018, 8(3): 15-. |
[14] | ZHU Min1, LI Ling-hai2.Advances in Research on Application of Anesthetics and Postoperative Cognitive Dysfunction in Patients[J]. Acta Neuropharmacologica, 2018, 8(3): 32-. |
[15] | SUN Yi,TAN Bo,SU Rui-bin.Biased Ligand——Novel Paradigm for Opioid Analgesics[J]. Acta Neuropharmacologica, 2018, 8(2): 1-7. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||